EpCAM-negative CTC, thus undetected through CellSearch®, have been correlated with poor prognosis in colorectal cancer patients in the course of antiangiogenic treatment [26] as well as with the emergence of brain metastasis in triple-negative breast cancers [27]. Here, EPCAM is linked to triple-negative breast carcinoma.